Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNausea from Wegovy (semaglutide) typically begins within the first day or two after your first injection, with most people noticing it most sharply in the 24 to 72 hours that follow a new dose or a dose increase. Clinical trial data from the STEP 1 study, published in the New England Journal of Medicine, recorded nausea as the single most common side effect — affecting around 44% of participants on the 2.4mg maintenance dose, compared with about 16% on placebo. These are prescription-only medicines; whether semaglutide is clinically suitable for you is a decision made by a prescriber following a proper assessment, not something that can be determined from a side-effect profile alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial enrolled 1,961 adults and tracked side effects across 68 weeks of treatment. Nausea clustered heavily in the early weeks at each dose level, it was not a sustained, constant feature for most participants. The data showed rates of nausea falling noticeably after the first few weeks at a given dose, which fits with what we know about how the body adapts to GLP-1 receptor stimulation. When the prescriber increased the dose, a second wave of nausea was common, again peaking in the first 24–72 hours and then subsiding. This pattern repeats through the titration steps: 0.25mg, then 0.5mg, then 1.0mg, then 1.7mg, building to the 2.4mg maintenance dose over approximately five months. The gradual climb is not incidental, it is the mechanism by which most people avoid the worst of the GI effects.
If you want a broader picture of how quickly the medicine itself starts working beyond nausea, our page on how quickly Wegovy works covers appetite changes and early effects separately.
Semaglutide acts on GLP-1 receptors in the gut as well as the brain. One effect is a significant slowing of gastric emptying, food sits in the stomach for longer. That is part of why appetite falls and portion tolerance drops, but it is also directly responsible for the nausea, bloating and fullness that people notice in the early weeks. The brain's chemoreceptor trigger zone, which governs the vomiting reflex, also carries GLP-1 receptors; direct stimulation there contributes to queasiness independently of what is happening in the stomach itself.
A question our prescribers hear most weeks is whether nausea means the medicine is working. The honest answer is that nausea is a sign of GLP-1 activity, not a marker of efficacy on its own, people who experience minimal nausea can still see meaningful results, and people who feel very sick are not necessarily losing weight faster. As the NHS semaglutide patient page notes, GI side effects are a known and expected part of starting treatment, and most people do not need to stop because of them.
Not everyone experiences nausea at the same intensity or on the same timeline. Several things appear to make early nausea more pronounced: eating large meals, eating quickly, lying down soon after eating, and consuming fatty or very rich food. These are practical rather than clinical adjustments, smaller meals spaced through the day, eating slowly and staying upright for an hour or so after food can make a real difference. Hydration matters too; nausea on a nearly-empty stomach with too little fluid tends to feel worse. Alcohol can amplify GI discomfort in the early weeks and is worth limiting. None of these are formal prescriber instructions, for anything specific to your dose and situation, the prescriber and the Patient Information Leaflet are the right sources.
Individual biology also plays a part. People with a history of motion sickness or GI sensitivity tend to report earlier and stronger nausea. Starting at the lowest dose gives the gut the best chance to adjust, which is exactly why the titration schedule exists. If you are thinking about what to expect in the weeks ahead, our page on how long nausea typically lasts on Wegovy covers duration in more detail.
Ordinary early nausea (queasy, off food, occasionally sick) is expected and usually settles within days at each dose level. But certain symptoms warrant prompt medical attention and should not be waited out. Severe, persistent stomach pain that radiates toward the back, with or without vomiting, can indicate acute pancreatitis; this is an infrequent but serious risk that the MHRA highlighted in a Drug Safety Update in January 2026 specifically covering GLP-1 medicines. Stop and seek urgent help if that pattern appears. Similarly, vomiting that is severe enough to prevent you keeping fluids down raises the risk of dehydration, which can itself cause kidney strain, if you cannot stay hydrated, contact a healthcare professional rather than pushing through. Signs of an allergic reaction (facial swelling, difficulty breathing, rapid heartbeat alongside nausea) also need emergency attention.
For anyone tracking early results alongside these early side effects, the evidence on how quickly weight loss begins on Wegovy gives a realistic timeline grounded in the trial data. People often have related questions at this stage, including how quickly you feel Wegovy's effects in the first place and, looking at the same question from a slightly different angle, how quickly Wegovy takes effect overall, both of which are worth reading together. The cost of a private prescription is one practical consideration; our page on Wegovy pricing in the UK sets out what is typically included in a legitimate private prescription service.
If you would like to discuss whether Wegovy is a suitable option for you, start your free consultation with our prescribers, same-day clinical review, no waiting list.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.